Cardiovascular effects of intravenous and intracoronary administration of atrial natriuretic peptide in halothane anesthetized dogs

Ryoko Iwanaga, Shingo Hori, Hiromichi Suzuki, Sadao Nakajima, Takao Saruta, Shyoji Kojima, Keiichi Fukuda, Tohru Satoh, Masatoshi Kusuhara, Shunnosuke Handa, Yoshiro Nakamura, Keigo Yoshinaga, Kenn Yamaguchi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cardiovascular actions of synthetic 1-28 human natriuretic peptides (hANP) were examined in dogs anesthetized with halothane. In seven closed-chest dogs a Swan-Ganz catheter was inserted for measurement of cardiac output. Intravenous infusion of increasing doses of hANP (0.1, 0.3, 0.9ug/kg/min) lowered mena aortic pressure without affecting heart rate significantly. Cardiac output and pulmonary wedge pressure were markedly decreased while total peripheral resistance was increased significantly. All these parameters returned to control levels after 1hr of recovery with an 100-150ml of saline infusion to increase pulmonary capillary wedge pressure to the pre-infusion value. Intracoronary infusion of hANP (0.05 and 0.1ug/kg/min) did not cause any significant changes in coronary flow and regional contraction. These results indicate that the hypotensive action of hANP is due to a decrease in cardiac output mediated by reduced preload but not by negative inotropic action.

Original languageEnglish
Pages (from-to)1279-1286
Number of pages8
JournalLife Sciences
Volume42
Issue number13
DOIs
Publication statusPublished - 1988

Fingerprint

Natriuretic Peptides
Atrial Natriuretic Factor
Halothane
Intravenous Administration
Cardiac Output
Dogs
Pulmonary Wedge Pressure
Catheters
Capillarity
Level control
Intravenous Infusions
Vascular Resistance
Arterial Pressure
Thorax
Heart Rate
Recovery

ASJC Scopus subject areas

  • Pharmacology

Cite this

Cardiovascular effects of intravenous and intracoronary administration of atrial natriuretic peptide in halothane anesthetized dogs. / Iwanaga, Ryoko; Hori, Shingo; Suzuki, Hiromichi; Nakajima, Sadao; Saruta, Takao; Kojima, Shyoji; Fukuda, Keiichi; Satoh, Tohru; Kusuhara, Masatoshi; Handa, Shunnosuke; Nakamura, Yoshiro; Yoshinaga, Keigo; Yamaguchi, Kenn.

In: Life Sciences, Vol. 42, No. 13, 1988, p. 1279-1286.

Research output: Contribution to journalArticle

Iwanaga, R, Hori, S, Suzuki, H, Nakajima, S, Saruta, T, Kojima, S, Fukuda, K, Satoh, T, Kusuhara, M, Handa, S, Nakamura, Y, Yoshinaga, K & Yamaguchi, K 1988, 'Cardiovascular effects of intravenous and intracoronary administration of atrial natriuretic peptide in halothane anesthetized dogs', Life Sciences, vol. 42, no. 13, pp. 1279-1286. https://doi.org/10.1016/0024-3205(88)90221-4
Iwanaga, Ryoko ; Hori, Shingo ; Suzuki, Hiromichi ; Nakajima, Sadao ; Saruta, Takao ; Kojima, Shyoji ; Fukuda, Keiichi ; Satoh, Tohru ; Kusuhara, Masatoshi ; Handa, Shunnosuke ; Nakamura, Yoshiro ; Yoshinaga, Keigo ; Yamaguchi, Kenn. / Cardiovascular effects of intravenous and intracoronary administration of atrial natriuretic peptide in halothane anesthetized dogs. In: Life Sciences. 1988 ; Vol. 42, No. 13. pp. 1279-1286.
@article{8011f76ae42b461ea21085f08869f542,
title = "Cardiovascular effects of intravenous and intracoronary administration of atrial natriuretic peptide in halothane anesthetized dogs",
abstract = "Cardiovascular actions of synthetic 1-28 human natriuretic peptides (hANP) were examined in dogs anesthetized with halothane. In seven closed-chest dogs a Swan-Ganz catheter was inserted for measurement of cardiac output. Intravenous infusion of increasing doses of hANP (0.1, 0.3, 0.9ug/kg/min) lowered mena aortic pressure without affecting heart rate significantly. Cardiac output and pulmonary wedge pressure were markedly decreased while total peripheral resistance was increased significantly. All these parameters returned to control levels after 1hr of recovery with an 100-150ml of saline infusion to increase pulmonary capillary wedge pressure to the pre-infusion value. Intracoronary infusion of hANP (0.05 and 0.1ug/kg/min) did not cause any significant changes in coronary flow and regional contraction. These results indicate that the hypotensive action of hANP is due to a decrease in cardiac output mediated by reduced preload but not by negative inotropic action.",
author = "Ryoko Iwanaga and Shingo Hori and Hiromichi Suzuki and Sadao Nakajima and Takao Saruta and Shyoji Kojima and Keiichi Fukuda and Tohru Satoh and Masatoshi Kusuhara and Shunnosuke Handa and Yoshiro Nakamura and Keigo Yoshinaga and Kenn Yamaguchi",
year = "1988",
doi = "10.1016/0024-3205(88)90221-4",
language = "English",
volume = "42",
pages = "1279--1286",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "13",

}

TY - JOUR

T1 - Cardiovascular effects of intravenous and intracoronary administration of atrial natriuretic peptide in halothane anesthetized dogs

AU - Iwanaga, Ryoko

AU - Hori, Shingo

AU - Suzuki, Hiromichi

AU - Nakajima, Sadao

AU - Saruta, Takao

AU - Kojima, Shyoji

AU - Fukuda, Keiichi

AU - Satoh, Tohru

AU - Kusuhara, Masatoshi

AU - Handa, Shunnosuke

AU - Nakamura, Yoshiro

AU - Yoshinaga, Keigo

AU - Yamaguchi, Kenn

PY - 1988

Y1 - 1988

N2 - Cardiovascular actions of synthetic 1-28 human natriuretic peptides (hANP) were examined in dogs anesthetized with halothane. In seven closed-chest dogs a Swan-Ganz catheter was inserted for measurement of cardiac output. Intravenous infusion of increasing doses of hANP (0.1, 0.3, 0.9ug/kg/min) lowered mena aortic pressure without affecting heart rate significantly. Cardiac output and pulmonary wedge pressure were markedly decreased while total peripheral resistance was increased significantly. All these parameters returned to control levels after 1hr of recovery with an 100-150ml of saline infusion to increase pulmonary capillary wedge pressure to the pre-infusion value. Intracoronary infusion of hANP (0.05 and 0.1ug/kg/min) did not cause any significant changes in coronary flow and regional contraction. These results indicate that the hypotensive action of hANP is due to a decrease in cardiac output mediated by reduced preload but not by negative inotropic action.

AB - Cardiovascular actions of synthetic 1-28 human natriuretic peptides (hANP) were examined in dogs anesthetized with halothane. In seven closed-chest dogs a Swan-Ganz catheter was inserted for measurement of cardiac output. Intravenous infusion of increasing doses of hANP (0.1, 0.3, 0.9ug/kg/min) lowered mena aortic pressure without affecting heart rate significantly. Cardiac output and pulmonary wedge pressure were markedly decreased while total peripheral resistance was increased significantly. All these parameters returned to control levels after 1hr of recovery with an 100-150ml of saline infusion to increase pulmonary capillary wedge pressure to the pre-infusion value. Intracoronary infusion of hANP (0.05 and 0.1ug/kg/min) did not cause any significant changes in coronary flow and regional contraction. These results indicate that the hypotensive action of hANP is due to a decrease in cardiac output mediated by reduced preload but not by negative inotropic action.

UR - http://www.scopus.com/inward/record.url?scp=0023905819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023905819&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(88)90221-4

DO - 10.1016/0024-3205(88)90221-4

M3 - Article

VL - 42

SP - 1279

EP - 1286

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 13

ER -